Glucose variation doesn't affect microvascular complications

Glucose variation doesn't affect microvascular complications

(HealthDay)—Measures of glycemic variability in type 1 diabetes, based on complete quarterly 7-point glucose profiles, fail to provide evidence that glycemic variability contributes to the risk of development or progression of microvascular complications beyond the influence of mean glucose levels, according to a study published online April 12 in Diabetes Care.

John M. Lachin, Sc.D., from George Washington University in Rockville, Md., and colleagues utilized data from the Diabetes Control and Complications Trial to assess the association of glucose variability within and between quarterly 7-point glucose profiles and the development and progression of retinopathy, nephropathy, and cardiovascular autonomic neuropathy.

The researchers found that adjusting for mean blood glucose, no measure of within-day variability was associated with any outcome. There was a significant association between the longitudinal mean M-value (over time) and microalbuminuria, when adjusted for the longitudinal mean blood glucose and corrected for multiple tests using the Holm procedure.

"Overall, within-day glycemic variability, as determined from quarterly glucose profiles, does not play an apparent role in the development of beyond the influence of the mean ," the authors write.

More information: Abstract/Full Text (subscription or payment may be required)

Journal information: Diabetes Care

Copyright © 2017 HealthDay. All rights reserved.

Citation: Glucose variation doesn't affect microvascular complications (2017, April 18) retrieved 29 March 2023 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Continuous glucose monitoring improves quality of life in T1DM


Feedback to editors